ArticleScientific reports2026
A machine-learning-derived online screening tool for depressive symptoms in chronic digestive system diseases patients: a cross-sectional study with temporal validation from CHARLS.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Chronic digestive system diseases (CDSD) are common in older adults, and depressive symptoms are associated with poorer prognosis and quality of life. We developed a machine-learning screening model to identify prevalent depressive symptoms in individuals with CDSD using data from the China Health and Retirement Longitudinal Study (CHARLS). This study included 3762 participants with CDSD from the 2011 survey and examined 45 behavioral, health, psychological, and sociodemographic variables. Feature selection was performed using logistic regression and LASSO regression, and seven modeling approaches were compared. Temporal validation was conducted in participants who newly reported physician-diagnosed CDSD in the 2015 CHARLS wave, with model inputs and depressive symptoms measured in the same wave. Among 3762 participants, 1900 had depressive symptoms. Thirteen variables were retained, including education, residence, life assessment, health assessment, fall history, disability, kidney disease, arthritis, heart disease, eyesight, instrumental activities of daily living, sleep duration, and grip strength. XGBoost was selected as the final model, achieving an area under the curve of 0.793 and an F1-score of 0.724 in the testing set, with acceptable calibration. These findings suggest that machine-learning approaches may support preliminary screening of existing depressive symptoms in people with CDSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.